Morgan Stanley Cure Vac N.V. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Cure Vac N.V. stock. As of the latest transaction made, Morgan Stanley holds 145,681 shares of CVAC stock, worth $362,745. This represents 0.0% of its overall portfolio holdings.

Number of Shares

145,681

Previous 307,905 52.69%

Holding current value

$362,745

Previous $1.05 Million 59.08%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.74 - $3.79 $444,493 - $614,828	-162,224 Reduced 52.69%	145,681 $428,000
Q2 2024 Oct 17, 2024	SELL	$2.31 - $4.99 $1.24 Million - $2.68 Million	-536,319 Reduced 63.53%	307,905 $1.05 Million
Q2 2024 Aug 14, 2024	SELL	$2.31 - $4.99 $1.24 Million - $2.68 Million	-536,319 Reduced 63.53%	307,905 $1.05 Million
Q1 2024 Oct 17, 2024	BUY	$2.94 - $4.34 $1.58 Million - $2.33 Million	536,319 Added 174.18%	844,224 $2.56 Million
Q1 2024 Aug 16, 2024	BUY	$2.94 - $4.34 $918,785 - $1.36 Million	312,512 Added 58.77%	844,224 $2.56 Million
Q1 2024 May 15, 2024	BUY	$2.94 - $4.34 $918,785 - $1.36 Million	312,512 Added 58.77%	844,224 $2.56 Million
Q4 2023 Aug 16, 2024	BUY	$3.96 - $6.41 $886,275 - $1.43 Million	223,807 Added 72.69%	531,712 $2.24 Million
Q4 2023 Feb 13, 2024	BUY	$3.96 - $6.41 $1.31 Million - $2.12 Million	330,410 Added 164.14%	531,712 $2.24 Million
Q3 2023 Nov 15, 2023	SELL	$6.5 - $10.77 $2.2 Million - $3.65 Million	-339,230 Reduced 62.76%	201,302 $1.37 Million
Q2 2023 Aug 14, 2023	BUY	$6.69 - $12.25 $2.08 Million - $3.8 Million	310,280 Added 134.76%	540,532 $5.63 Million
Q1 2023 May 15, 2023	SELL	$6.38 - $12.5 $678,538 - $1.33 Million	-106,354 Reduced 31.6%	230,252 $1.6 Million
Q4 2022 Feb 14, 2023	BUY	$5.75 - $8.5 $99,538 - $147,143	17,311 Added 5.42%	336,606 $2.03 Million
Q3 2022 Nov 14, 2022	SELL	$7.48 - $15.24 $43,817 - $89,275	-5,858 Reduced 1.8%	319,295 $2.52 Million
Q2 2022 Oct 27, 2022	BUY	$13.18 - $19.41 $2.06 Million - $3.03 Million	155,996 Added 92.22%	325,153 $4.43 Million
Q2 2022 Aug 15, 2022	BUY	$13.18 - $19.41 $2.06 Million - $3.03 Million	155,996 Added 92.22%	325,153 $4.43 Million
Q1 2022 Oct 27, 2022	SELL	$14.73 - $35.25 $2.3 Million - $5.5 Million	-155,996 Reduced 47.98%	169,157 $3.32 Million
Q1 2022 May 13, 2022	BUY	$14.73 - $35.25 $1.14 Million - $2.73 Million	77,531 Added 84.62%	169,157 $3.32 Million
Q4 2021 Feb 14, 2022	BUY	$33.72 - $48.22 $785,001 - $1.12 Million	23,280 Added 34.06%	91,626 $3.15 Million
Q3 2021 Nov 15, 2021	BUY	$49.26 - $74.5 $3.37 Million - $5.09 Million	68,346 New	68,346 $3.73 Million

Others Institutions Holding CVAC

# of Institutions

Shares Held

12.3M

Call Options Held

164K

Put Options Held

117K

View Full List

About CureVac N.V.

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $467M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

More about CVAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account